Home / Stocks / ELV

Elevance Health (ELV, Managed Health Care) Stock Valuation & Fair Value Fairly valued

Elevance Health (ELV, Managed Health Care) trades at a blended P/E of 14.6 — about 8% above its historical normal valuation — with a forward growth estimate of 7.4% and a PEG of 1.99. Analysts' one-year estimates have been hit 64% of the time.

DATA AS OF 2026-07-14
Blended P/E
14.6
Normal P/E
13.5
PEG
1.99
Fwd growth
7.4%
Div yield
1.6%

Valuation flags

Verdict history

tickerseer's rating has been fairly valued since 2026-06-03.

2026-06-03P/E 13.6+1%Fairly valued
2026-06-10P/E 14.4+7%Fairly valued
2026-06-14P/E 14.4+7%Fairly valued
2026-06-16P/E 14.4+7%Fairly valued
2026-06-21P/E 14.4+7%Fairly valued
2026-07-02P/E 14.6+8%Fairly valued
2026-07-06P/E 14.6+8%Fairly valued
2026-07-09P/E 14.6+8%Fairly valued
2026-07-12P/E 14.6+8%Fairly valued
2026-07-13P/E 14.6+8%Fairly valued
2026-07-14P/E 14.6+8%Fairly valued ← now

Frequently asked questions

Is Elevance Health stock overvalued?

At a blended P/E of 14.6 versus its historical normal P/E of 13.5, Elevance Health trades about 8% above its typical valuation, with a PEG of 1.99 on 7.4% forward growth — tickerseer currently rates it fairly valued.

What is Elevance Health's fair value and PEG?

Elevance Health trades at a blended P/E of 14.6 against a historical normal P/E of 13.5, a PEG of 1.99, and a forward growth estimate of 7.4%.

Has tickerseer's rating of Elevance Health changed?

tickerseer's rating has been fairly valued since 2026-06-03.

Industry: Managed Health Care. Create a free account to unlock the full analysis — the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track ELV free — valuation & earnings alerts